Ubrogepant Combined With OnabotulinumtoxinA Effective for Breakthrough Migraine
Presenting at AHS 2022, researchers evaluated the real-world effectiveness of ubrogepant in combination with onabotulinumtoxinA to treat breakthrough migraine.
Maria Arini Lopez, PT, DPT, CSCS, CMTPT
Maria Arini Lopez, PT, DPT, is a freelance medical writer and editor from Maryland. She has expertise in the therapeutic areas of orthopedics, neurology, chronic pain, gastrointestinal dysfunction, and rare diseases, especially Ehlers-Danlos syndrome.
